Lv31
348 积分 2025-02-25 加入
Comprehensive Evaluation of 10 Docking Programs on a Diverse Set of Protein–Cyclic Peptide Complexes
13天前
已完结
TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review
19天前
已完结
The TL1A inhibitors in IBD: what’s in the pot?
19天前
已完结
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
26天前
已完结
Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches
27天前
已完结
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
27天前
已完结
Perspectives on Fragment-based Drug Discovery: A Strategy Applicable to Diverse Targets
1个月前
已完结
Small molecule-drug conjugates: Mechanistic insights and strategic design for enhanced cancer therapy
1个月前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
1个月前
已完结
Discovery of novel ULK1 inhibitors through machine learning-guided virtual screening and biological evaluation
2个月前
已完结
皖公网安备34019202002308
